Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impendia: Glucose-sparing PD solutions in diabetic patients
NCT00567489Phase 4Completed
- Sponsor
- Vanttive
- Start
- Jan 2008
- Primary completion
- Jul 2011
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 5
01
Overview
A Phase 4 trial of Physioneal, icodextrin, Nutrineal in end stage renal disease (ESRD), sponsored by Vanttive. Started Jan 2008; status: completed.
02
Drugs
PhysionealicodextrinNutrineal
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00567489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567489.